Código QR (código de barras bidimensional)

GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives

Obstructive sleep apnea syndrome (OSAS) is closely associated with obesity and metabolic dysfunction. Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated superior efficacy for weight reduction and improved metabolic health compared with single GLP-1 agonists. Emerging evidence indic...

תיאור מלא

שמור ב:
Principais autores: Qiujie Fang, Yipeng Zhu, Mei Rao, Peijun Liu
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2026-04-01
סדרה:Frontiers in Medicine
נושאים:
GLP-1/GIP dual agonist
metabolic regulation
obesity
obstructive sleep apnea
tirzepatide
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fmed.2026.1752341/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים